We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

48 hedge funds and large institutions have $240M invested in Autolus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

22.89% more ownership

Funds ownership: 0% → 22.89% (+23%)

Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WIM
Woodford Investment Management
United Kingdom
+$42.1M
2
CAM
Cormorant Asset Management
Massachusetts
+$40.3M
3
Capital World Investors
Capital World Investors
California
+$29.1M
4
AI
Alphabet Inc
California
+$18.9M
5
AG
Artal Group
Luxembourg
+$13.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Man Group
26
Man Group
United Kingdom
$1.07M +$1.06M +40,000 New
EIM
27
Essex Investment Management
Massachusetts
$1.01M +$997K +37,742 New
GCP
28
GSA Capital Partners
United Kingdom
$960K +$947K +35,851 New
MWNA
29
Marshall Wace North America
New York
$954K +$941K +35,600 New
N
30
Nuveen
North Carolina
$832K +$821K +31,061 New
MCM
31
Marsico Capital Management
Colorado
$670K +$661K +25,000 New
TAM
32
TFG Asset Management
Cayman Islands
$670K +$661K +25,000 New
MS
33
Maven Securities
Jersey
$511K +$529K +20,000 New
Janus Henderson Group
34
Janus Henderson Group
United Kingdom
$498K +$491K +18,585 New
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$429K +$423K +16,000 New
IG
36
ING Group
Netherlands
$402K +$396K +15,000 New
PCM
37
Pentwater Capital Management
Florida
$402K +$396K +15,000 New
PCM
38
Prelude Capital Management
New York
$326K +$321K +12,166 New
TD Asset Management
39
TD Asset Management
Ontario, Canada
$258K +$255K +9,649 New
William Blair & Company
40
William Blair & Company
Illinois
$236K +$233K +8,800 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$191K +$188K +7,112 New
Barclays
42
Barclays
United Kingdom
$162K +$160K +6,052 New
BlackRock
43
BlackRock
New York
$132K +$130K +4,937 New
PIM
44
Partner Investment Management
California
$57K +$56.2K +2,126 New
FIA
45
FNY Investment Advisers
New York
$13K +$13.2K +500 New
UBS Group
46
UBS Group
Switzerland
$8K +$7.72K +292 New
Wells Fargo
47
Wells Fargo
California
$7K +$6.61K +250 New
CCA
48
Catalyst Capital Advisors
New York
$6K +$5.92K +224 New
PC
49
Polar Capital
United Kingdom
$1.34K +$1.32M +50,000 New
1
2

AUTL Hedge Fund Activity: Q2 2018 in Review

48 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q2 2018, worth a combined $240M.

Buyers outnumbered sellers: 48 funds opened new AUTL positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Woodford Investment Management, opening a new position worth an estimated $42.1M.

  • 48 institutional investors held Autolus Therapeutics (AUTL) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $240M of Autolus Therapeutics stock for Q2 2018.
  • 48 funds opened new Autolus Therapeutics positions in Q2 2018 and 0 closed out, a net change of +48 holders.
  • The largest Autolus Therapeutics buyer in Q2 2018 was Woodford Investment Management, an estimated $42.1M added.

Based on aggregated 13F filings for Q2 2018.